ARTICLE | Company News
NEUS, Rheoscience obesity deal
June 10, 2004 7:00 AM UTC
Rheoscience will validate potential drug targets for NeuroSearch (CSE:NEUR) to treat obesity. Rheoscience also will test selected compounds from NEUS's compound library for anti-obesity activity. NEUS...